Zenas Technologies Exhibiting at ACT Annual Meeting in November

New Orleans, Louisiana (October 2011)– Zenas Technologies will be in Phoenix at the 32nd American College of Toxicology meeting, in booth 154, November 6th through the 9th.

“We welcome the opportunity to share more information about our cardiac ion channel and CNS assays,” says Dr. William Crumb, Zenas Founder and Scientific Director. “I look forward to explaining how we leverage the scientific advantages of our comprehensive assays, from utilizing native human cardiac myocytes at physiologic temperatures to screening compounds against neuronal ion channels in our CNS screenings.”

Zenas Technologies will be meeting with clients and colleagues, as well as scheduling one-on-one appointments, to discuss their proprietary models, proven data packages and consulting services.

“We unveiled our new look and brand image at the Safety Pharmacology Society trade show several weeks ago,” says Brent Kovach, Zenas Business Development Director. “It gave us a platform to clearly communicate our services, capabilities and what differentiates us in the marketplace. We look forward to building on this momentum in Phoenix.”

"Zenas Technologies is a contract research organization dedicated to providing accurate, predictive assays and in-depth expert analysis for clients looking for answers to their cardiovascular and central nervous systems questions. Having screened thousands of compounds against a variety of ion channels, Zenas offers comprehensive protocol design, technical oversight and consulting.

To schedule time with the Zenas Technologies team, please contact
Brent Kovach at: bkovach@zenastech.com.

For more information about Zenas Technologies, please visit www.zenastech.com.

Dr. William Crumb, Founder/Scientific Director of Zenas Technologies

Brent Kovach, Director of Business Development

Back to News & Events